Octanoic Acid.
Research-backed compound with potential health benefits. 8-carbon saturated fat. Also called caprylic acid or C8.
Reviewed March 2026
- Category
- Compound
What Octanoic Acid is, and what it does.
- Does it work
- Excellent for ketone production and mental energy. Worth the premium over mixed MCT.
- How much to take
- Start with 5 to 15g a day, the daily maintenance band, split across the day and taken with food. Trials used 30g, which is a research condition rather than a daily target.
- Time to feel it
- Blood ketones climb within 30 to 60 minutes of a dose and peak inside a couple of hours. That is a measured change, and how much of it you notice varies.
- The first dose
- Many people feel a mild lift within an hour or two. A large first dose often brings loose stools or gurgling, which is why a smaller starting amount is the usual advice.
- With regular use
- Weeks of daily use keep a repeatable ketone rise available as fuel alongside glucose. The digestive side usually settles within the first week or two.
- How well tolerated
- Well tolerated when you build up slowly with food. Going up too fast brings loose stools and cramping. Check with your doctor first if you take medication or have digestive concerns.
- How it feels
- A clean, slightly warm mental lift for some people and nothing dramatic for others. The oil feels oily and can catch the throat, which the powdered version softens.
- The overlooked benefit
- Octanoate is the exact acyl group your body attaches to ghrelin to make it active, and it is the backbone your cells build lipoic acid from. Small molecule, two very specific jobs.
5 to 15g a day is where Octanoic Acid works.
Source: Henderson et al., Nutr Metab, 2009; MCT oil studies (C8 caprylic acid)
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Octanoic Acid is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Blood ketone elevation after a doseMeta-analysis
- Body weight and waist measures with medium-chain triglyceridesMeta-analysis
- Energy expenditure and satiety ratingsRandomised trial
- Cognitive test scores in older adultsRandomised trial
- Carnitine-independent entry to mitochondrial beta-oxidationIn vitro study
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Octanoic acid is the C8 fatty acid esterified into medium chain triglycerides and released by gut lipase. MCT oil is the delivery form the free acid comes from.
Octanoic acid goes by the portal vein to the liver and is oxidised to acetyl-CoA that feeds ketogenesis. Exogenous beta-hydroxybutyrate supplies the same circulating ketone directly, so the two raise the pool by different routes.
Hepatic oxidation of octanoic acid produces acetoacetate and then D-beta-hydroxybutyrate. Dosing the two together stacks the endogenous and exogenous sources of one molecule.
Octanoic acid crosses the inner mitochondrial membrane largely without the carnitine shuttle, whereas long chain fatty acids need CPT1 and carnitine. Pairing them covers fatty acid entry across both chain lengths.
Ubiquinone is highly lipophilic and poorly absorbed from dry powder. Dissolving it in a C8-rich medium chain oil forms the mixed micelles that carry it across the gut.
Curcuminoids are practically water insoluble and depend on a lipid phase for uptake. Medium chain fatty acid vehicles are routinely used to get them into micelles.
Octanoate is the direct carbon skeleton for endogenous lipoic acid synthesis: octanoyl-ACP is transferred onto the target protein and then sulfur atoms are inserted by lipoyl synthase. That makes octanoic acid the precursor and lipoic acid the product in the same pathway. Supplemental lipoic acid bypasses the pathway entirely rather than adding to it, which is the honest way to state the relationship.
Medium-chain acyl-CoA dehydrogenase, the first step of beta-oxidation for a C8 chain, is an FAD-dependent enzyme, and FAD comes from riboflavin. Electron transfer flavoprotein downstream is also flavin-dependent. Adequate riboflavin is therefore a requirement for the pathway that burns octanoate, not an enhancer of it.
Octanoic acid has to be activated to octanoyl-CoA before anything else can happen to it, and coenzyme A is built from pantothenic acid. Every turn of beta-oxidation also releases acetyl-CoA, which consumes the same CoA pool. This is textbook activation chemistry.
Beta-oxidation generates NADH at the hydroxyacyl-CoA dehydrogenase step, and ketone body formation and interconversion also run on NAD-linked reactions. NAD is derived from niacin. The cofactor requirement is settled biochemistry and does not depend on any supplement study.
Unlike long-chain fats, medium-chain fatty acids need little bile and little micelle formation, and they are absorbed directly into portal blood rather than packaged into chylomicrons. Adding bile salts therefore does much less for a C8 fatty acid than for a long-chain oil. Stating that clearly is more useful than implying a partnership.
Free octanoic acid needs no lipase at all, while a C8 triglyceride does require lipase to release it, although gastric and lingual lipases already handle medium-chain triglycerides efficiently. Supplemental lipase matters more to the triglyceride form than to the free acid. The distinction depends on which form is on the label.
Taurine conjugates bile acids and so shapes the fat-emulsifying pool, which matters little for a medium-chain fatty acid that largely bypasses that route. The pair is often co-formulated in energy products rather than mechanistically linked. Read it as formulation convention.
Lecithin is used to emulsify C8 oil into powders and beverages and to keep an emulsion from separating on the shelf. The role is physical stability and mouthfeel, not absorption, since the fatty acid is already well absorbed. It is a formulation aid.
Butyrate is a four-carbon fatty acid and octanoate an eight-carbon one, and both enter mitochondrial beta-oxidation without needing the carnitine shuttle that long-chain fats require. Both also yield acetyl-CoA that can feed hepatic ketone production. Their tissue destinations differ, since butyrate is largely consumed by colonocytes.
Leucine is a ketogenic amino acid whose carbon skeleton is degraded to acetoacetate and acetyl-CoA, the same endpoints that C8 oxidation feeds. Combining them supplies the ketogenic pool from two directions. This describes substrate flow, not an effect on any measured outcome.
Glutamine is the preferred fuel of small intestine enterocytes and medium-chain fatty acids are absorbed and partly oxidised by the same cells. The two supply gut-wall energy through separate routes. This is a mechanistic overlap and no combination data exists.
Free medium-chain fatty acids including octanoic acid disrupt microbial membranes in laboratory work, which is why caprylic acid appears in yeast-balance products. A live yeast probiotic is itself a microorganism and the same membrane activity applies to it. Separating the doses by several hours is the practical reading.
The antimicrobial behaviour of free medium-chain fatty acids in vitro is not selective, so a free C8 acid taken at the same moment as live cultures can reduce the number of organisms that survive transit. Delivering the C8 as a triglyceride rather than the free acid lessens this. The interaction is in vitro chemistry rather than a measured human result.
A structured lipid combining eicosapentaenoic acid with medium-chain triacylglycerol has been studied in people for muscular endurance measures, which is a combination product rather than two separate doses. The C8 provides the medium-chain portion of that structured lipid. The endpoint was a performance measure in a specific protocol, so it does not generalise to any C8 and any fish oil taken together.
Medium-chain triglycerides combined with docosahexaenoic acid have been given together in a human cognitive-function study, with the two lipids serving different roles, one as a rapidly oxidised fuel and one as a structural fatty acid. The result belongs to the combination, and the contribution of the C8 fraction alone cannot be separated out.
C8 oil and caffeine are combined in morning beverages where one supplies rapidly oxidised fat-derived fuel and the other acts on adenosine receptors. The mechanisms do not touch. Any combined effect is two separate effects arriving at once.
Carnitine is required to move long-chain fatty acids into mitochondria, and octanoate is notable precisely because it does not need that shuttle. Adding carnitine therefore does little for C8 oxidation specifically, though it affects the long-chain fats eaten alongside it. Saying so is more accurate than claiming a partnership.
Nothing specific on file for Octanoic Acid. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Octanoic Acid actually does.
Octanoic acid is caprylic acid, the eight-carbon saturated fatty acid, and it is the C8 component of medium-chain triglyceride oils alongside the ten-carbon decanoic acid.
Medium-chain fatty acids are absorbed across the enterocyte and pass into portal blood bound to albumin, rather than being re-esterified into chylomicrons and entering the lymph as long-chain fats do.
An eight-carbon acyl chain crosses the inner mitochondrial membrane without requiring carnitine palmitoyltransferase, which is why C8 reaches beta-oxidation faster than a long-chain fatty acid.
Octanoate is activated to octanoyl-CoA and oxidised by medium-chain acyl-CoA dehydrogenase, releasing acetyl-CoA that the liver can condense into acetoacetate and beta-hydroxybutyrate.
Where Octanoic Acid comes from.
It comes out of coconut or palm kernel oil. The fat is split into its individual fatty acids, then distilled so the eight-carbon ones can be pulled away from the rest. Pure C8 costs more than a mixed MCT oil because that separation step is the expensive part.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Both oils are naturally rich in medium-chain fatty acids, with coconut oil carrying roughly seven to ten percent C8 alongside larger amounts of lauric acid. Palm kernel oil has a similar profile and is the cheaper feedstock in many markets.
The triglycerides are split with high-pressure steam or by enzymatic hydrolysis, releasing free fatty acids and glycerol. Some routes instead transesterify directly.
The mixed fatty acids are separated by chain length under vacuum. The C8 cut is taken off separately from the C10 and the much larger C12 lauric fraction, which is what makes a pure C8 product possible and more expensive than a C8 and C10 blend.
For triglyceride products the purified C8 acid is re-esterified onto glycerol to form tricaprylin. Free-acid products skip this step.
Gas chromatography confirms the C8 percentage and the residual C10 and C12 content. A label saying C8 rather than MCT is a claim about this assay.
The oil is bottled, spray-dried onto a fibre carrier, filled into softgels, or neutralised to the sodium salt for dry blending.
Getting Octanoic Acid from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In mice, pregnancy stimulated the ghrelin and pituitary growth hormone axis while dietary octanoic acid supplementation did not produce a detectable change in that axis; a failure to detect is not proof of no effect.Animal study. Kaur H et al., 2020 (The Journal of endocrinology). PMID 32176867 ↗
- Octanoic acid-rich enteral nutrition was reported to lessen metabolic disturbance in an animal model of systemic inflammatory challenge, with suppressed white adipose tissue lipolysis given as the mechanism.Animal study. Zheng C et al., 2026 (Food science & nutrition). PMID 42282442 ↗
- Octanoic acid was reported to lessen cold-induced low-mood behaviours in an animal model, with the AKR1B1 and prostaglandin F2 alpha pathway identified as the target.Animal study. Liu Z et al., 2026 (iScience). PMID 42211124 ↗
- In a randomised, double-blind, controlled design, medium-chain triglycerides combined with moderate-intensity exercise were assessed against control; the C8 fraction was one component of the intervention and is named rather than isolated.Randomised trial. Kojima K et al., 2023 (Nutrients). PMID 37513691 ↗
- The authors identify C8 and C10 medium-chain fatty acids among the bioactive fractions in their assays, which characterises the molecules rather than showing an effect in people.In vitro study. Cho KH et al., 2026 (Antioxidants). PMID 42193228 ↗
- Gut microbial metabolic output including medium-chain fatty acid handling shifted under probiotic and postbiotic conditions in a laboratory gut model; octanoic acid appears as a measured metabolite.In vitro study. Batra N et al., 2026 (Food & function). PMID 42021724 ↗
These are the studies our verdict leans on, chosen from the 6 we read for Octanoic Acid. The full linked list is below.
The studies, linked.
3 sources behind our Octanoic Acid verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trial13C-Octanoic Acid Breath Test for the Evaluation of a Low-fodmaps Diet on Gastric Emptying in Celiac Patients With Functional DisordersClinicalTrials.gov ↗NA · 68 participants · Completed
- Clinical trialEffects of Octanoic Acid for Treatment of Essential Voice TremorClinicalTrials.gov ↗PHASE1 · 17 participants · Completed
- Clinical trialA Phase I/II Open-Label Dose Escalation Trial of CPI-613 in Combination With Docetaxel Chemotherapy as a Second-Line Treatment of Non-Small-Cell Lung CancerClinicalTrials.gov ↗PHASE1 · Withdrawn
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.